» Authors » Jennifer L Schneider

Jennifer L Schneider

Explore the profile of Jennifer L Schneider including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 97
Citations 1677
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Coronado G, Nyongesa D, Escaron A, Petrik A, Thompson J, Smith D, et al.
Cancer Epidemiol Biomarkers Prev . 2023 Aug; 32(11):1608-1616. PMID: 37566431
Background: Mailed fecal immunochemical test (FIT) outreach can improve colorectal cancer screening rates, yet little is known about how to optimize these programs for effectiveness and cost. Methods: PROMPT was...
12.
Schneider J, Rivelli J, Vaughn K, Thompson J, Petrik A, Escaron A, et al.
Transl Behav Med . 2023 May; 13(10):757-767. PMID: 37210075
Colorectal cancer (CRC) is a leading cause of cancer death in the USA. Screening programs in federally qualified health centers (FQHCs) are essential to reducing CRC-related mortality and morbidity among...
13.
Salvati Z, Rahm A, Williams M, Ladd I, Schlieder V, Atondo J, et al.
Implement Sci Commun . 2023 Apr; 4(1):43. PMID: 37098602
Background: Identifying key determinants is crucial for improving program implementation and achieving long-term sustainment within healthcare organizations. Organizational-level complexity and heterogeneity across multiple stakeholders can complicate our understanding of program...
14.
Mayhew M, Balderson B, Cook A, Dickerson J, Elder C, Firemark A, et al.
Trials . 2023 Mar; 24(1):196. PMID: 36927459
Background: Cognitive behavioral therapy for chronic pain (CBT-CP) is an effective but underused treatment for high-impact chronic pain. Increased access to CBT-CP services for pain is of critical public health...
15.
Thomas M, Su Y, Rosenthal E, Sakoda L, Schmit S, Timofeeva M, et al.
medRxiv . 2023 Feb; PMID: 36789420
Polygenic risk scores (PRS) have great potential to guide precision colorectal cancer (CRC) prevention by identifying those at higher risk to undertake targeted screening. However, current PRS using European ancestry...
16.
Su Y, Sakoda L, Jeon J, Thomas M, Lin Y, Schneider J, et al.
Cancer Epidemiol Biomarkers Prev . 2023 Jan; 32(3):353-362. PMID: 36622766
Background: Polygenic risk scores (PRS) which summarize individuals' genetic risk profile may enhance targeted colorectal cancer screening. A critical step towards clinical implementation is rigorous external validations in large community-based...
17.
Hunter J, Schneider J, Firemark A, Davis J, Gille S, Pawloski P, et al.
J Patient Cent Res Rev . 2022 Nov; 9(4):282-289. PMID: 36340570
Purpose: Genetic information has health implications for patients and their biological relatives. Death of a patient before sharing a genetic diagnosis with at-risk relatives is a missed opportunity to provide...
18.
Yarborough B, Stumbo S, Schneider J, Richards J, Hooker S, Rossom R
BMC Psychiatry . 2022 Jul; 22(1):494. PMID: 35870919
Background: Suicide risk prediction models derived from electronic health records (EHR) and insurance claims are a novel innovation in suicide prevention but patient perspectives on their use have been understudied....
19.
Fitzpatrick S, Papajorgji-Taylor D, Schneider J, Lindberg N, Francisco M, Smith N, et al.
Transl Behav Med . 2022 Jul; 12(7):783-792. PMID: 35849138
Social needs contribute to persistent diabetes disparities; thus, it is imperative to address social needs to optimize diabetes management. The purpose of this study was to determine determine the feasibility...
20.
Schneider J, Firemark A, Papajorgji-Taylor D, Reese K, Thorsness L, Sullivan M, et al.
J Am Pharm Assoc (2003) . 2022 Jun; 63(1):241-251.e1. PMID: 35718714
Background: Opioid tapering has been identified as an effective strategy to prevent the dangers associated with long-term opioid therapy for patients with chronic pain. However, many patients are resistant to...